22157.jpg
Worldwide Ophthalmology Industry to 2027 - Surge in Research and Development to Provide New Treatment Presents Opportunities
January 18, 2022 05:08 ET | Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been...
Gentex Announces Partnership With eSight To Develop Next Generation Digital Eyewear
January 03, 2022 08:00 ET | Gentex Corporation
LAS VEGAS, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX) announced today prior to CES that it’s partnering with eSight, a leading provider of vision enhancement technology, to...
Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome® AMD Home Monitoring Tests
November 30, 2021 08:00 ET | Notal Vision
Manassas, VA, Nov. 30, 2021 (GLOBE NEWSWIRE) -- The Notal Vision Monitoring Center celebrates the artificial intelligence (AI) based analysis of the ten millionth test performed by over 20,000...
22157.jpg
Global Retinal Surgery Device Market (2021 to 2027) - Featuring Topcon, Alcon and Carl Zeiss Among Others
October 25, 2021 04:33 ET | Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Retinal Surgery Device Market, Global Forecast, Impact of COVID-19, Industry Trends, by Product, Growth, Opportunity Company Analysis" report has been...
22157.jpg
Outlook on the Glaucoma Therapeutics Global Market to 2026 - by Drug Class, Indication, End-user and Region
October 22, 2021 08:13 ET | Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
retro.jpg
Positive Results from Studies of Retrotope’s RT011 in Animal Models of Retinal Degeneration to be Featured in Oral Presentations at 2nd Annual Dry AMD Therapeutic Development Summit
October 19, 2021 07:00 ET | Retrotope
Data Demonstrate RT011 Offers Dose-Dependent Protection Against Retinal Lipid Peroxidation (LPO) and Cell Damage, as well as Preservation of Visual Function Findings Provide Rationale for Advancement...
Notal Vision Reports Results from First U.S. Home OCT Feasibility Study
October 12, 2021 08:00 ET | Notal Vision
Manassas, VA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that results of the first U.S.-based feasibility study with its investigational home-based optical coherence...
22157.jpg
Worldwide Choroidal Neovascularization Industry to 2026 - Featuring Novartis, Pfizer and Regeneron Pharmaceuticals Among Others
September 30, 2021 06:53 ET | Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
22157.jpg
Europe Age-Related Macular Degeneration Market and Competitive Landscape Report 2021
September 20, 2021 04:38 ET | Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe...
22157.jpg
Europe Dry Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021-2026
September 10, 2021 03:23 ET | Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. ...